Dr. Shore awarded the LUGPA Presidential Citation

Dr. Shore was awarded the prestigious LUGPA Presidential Citation in recognition of his lifetime achievements in establishing LUGPA’s Continuing Medical Education programs as a priority for the organization and ensuring that LUGPA’s programs remain on the cutting edge of clinical excellence. Presented on the third day of November, 2023.

click to listen to Dr. Shore’s acceptance speech

The New England Journal of Medicine, 10/19/23

The New England Journal of Medicine, 10/19/23
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate
Stephen J. Freedland, M.D., Murilo de Almeida Luz, M.D., Ugo De Giorgi, M.D., Ph.D., Martin Gleave, M.D., Geoffrey T. Gotto, M.D., M.P.H., Christopher M. Pieczonka, M.D., Gabriel P. Haas, M.D., Choung-Soo Kim, M.D., Miguel Ramirez-Backhaus, M.D., Antti Rannikko, M.D., Ph.D., Jamal Tarazi, M.D., M.P.A., Swetha Sridharan, M.B., B.S., Jennifer Sugg, M.S., Yiyun Tang, Ph.D., Ronald F. Tutrone, Jr., M.D., Balaji Venugopal, M.B., B.S., M.D., Arnauld Villers, M.D., Ph.D., Henry H. Woo, M.B., B.S., D.Med.Sc., Fabian Zohren, M.D., Ph.D., and Neal D. Shore, M.D.

Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava

Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava

Dr. Shore named 2023 Slotkin Lecturer for Outstanding Lecture

Congratulations to Dr. Neal D. Shore for being awarded the NSAUA 2023 Slotkin Lecturer for the outstanding lecture entitled “Current Therapy of Advanced GU Malignancies and Incorporating Clinical Trials Into Your Practice” October 20-22, 2023.

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial

Neal D. Shore, MD, FACS, co-author

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer
July 12, 2023

Neal Shore, MD, FACS; David Wise, MD, PhD; and Sarah Nielsen Young, MS, LCGC
To read entire article, please click this link

AUA Chicago April 28 – May 1, 2023- Here We Come

Our very own Neal D. Shore, MD, FACS, CURC Director, CPI (Certified Principal Investigator by the Association of Clinical Research Professionals) and Jennifer Sutton, RN, Certified Clinical Research Coordinator, Director of Nursing and Administration, will be attending AUA (American Urological Association) in Chicago at the end of April. https://www.auanet.org/aua2023

Dr. Shore will also be co-moderating an Independent Practice Symposium being Saturday, April 29, 2023, from 7:30 – 11:30 am CT at the AUA Annual Meeting in Chicago. #amerurological


Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303

Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, Neal Shore, J Alfred Witjes, Gary Steinberg, Jens Bedke, Hiroyuki Nishiyama, Xiao Fang, Ritesh Kataria, Eric Sbar, Xieyang Jia & Arlene Siefker-Radtke

Click here to read the Future Medicine article.

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

Bilal Chughtai, Sirikan Rojanasarot, Kurt Neeser, Dmitry Gultyaev, Stacey L. Amorosi, Neal D. Shore

Click here to read the article.